BAJAJ FINSERV DIRECT LIMITED
Latest IPO Information

Suraksha Diagnostic Ltd. IPO

IPO Date: Nov 29 to Dec 3 2024

Listing Date: Dec 6 2024

Objective


IPO Details

Face Value ₹ 2.00 Per Share
Issue Size ₹ 564.17 - 592.37 Cr
Price Band ₹ 420.00 - ₹ 441.00 Per Share
Market LOT 34 shares
Issue Type Book building

About Company

We are the largest full-service and integrated diagnostic chain headquartered in east India, by operating income as of Fiscal 2023. (Source: CRISIL Report). We also reported the highest compounded annual growth rate (“CAGR”) of 20.87% in terms of non-COVID revenues between Fiscals 2022 and 2024 among peers Agilus Diagnostics Limited, Dr. Lal Pathlabs Limited, Metropolis Healthcare Limited, Thyrocare Technologies Limited. (Source: CRISIL Report). We offer a one-stop integrated solution for pathology and radiology testing, and medical consultation services to our customers through our extensive .... operational network, consisting of our flagship central reference laboratory, 8 satellite laboratories (co-located with our diagnostic centers) and 194 customer touchpoints which include 48 diagnostic centres, and 146 sample collection centres (primarily franchised), as of March 31, 2024 across the states of West Bengal, Bihar, Assam, and Meghalaya. For details of our operational network, see “- Our Operational Network” on page 198. Our flagship central reference laboratory holds the College of American Pathologists accreditation. As of March 31, 2024, we are the only company providing diagnostic services and having a reference laboratory in East and North-East India to hold the College of American Pathologists accreditation. (Source: CRISIL Report). 3 of our laboratories hold National Accreditation Board for Testing and Calibration Laboratories (“NABL”) and 2 of our advanced diagnostic centres hold National Accreditation Board for Hospitals & Healthcare Providers (“NABH”) accreditations. As of March 31, 2024, 43 of our diagnostic centres also housed 120 polyclinic chambers hosting 750+ specialized doctors for patient convenience. During the Fiscal 2024, we conducted approximately 5.98 million tests serving approximately 1.14 million patients and derived 95.48% of our revenue from operations from our core geography, Kolkata and the rest of West Bengal. Read More
Address

Plot No D G-12/1, Action Area 1 D Premises No 02-0327, New Town Rajarhat

City

Kolkata

State

West Bengal

Pincode

700156

Phone

033-66059750

Email

investors@surakshanet.com

Website

www.surakshanet.com

About IPO

Listed At BSE/NSE
Lead Manager SBI Capital Markets Ltd
Promoters
Somnath Chatterjee
Ritu Mittal
Satish Kumar Verma

Promoter's Holding

Registrar

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

040 - 67162222/18003094001
einward.ris@kfintech.com
www.kfintech.com

Latest News

Mar
2
2026
EQUITY Posted on Mar 2nd 2026

Suraksha Diagnostic informs about resignation of chief financial officer (CFO)

Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, Suraksha Diagnostic has informed that the Company has received a letter from K S Ravindra on 02 March 2026, tendering his resignation from the position of Group Chief Financial Officer (CFO) designated as Key Managerial Personnel (KMP) of the Company. His last working day with the Company would be on or before 31 May 2026 (close of business hours). The Company places on record its deep sense of appreciation for the services rendered by K S Ravindra and for his contribution during his tenure as the Group CFO of the Company. The detailed disclosure as required under Regulation 30 read with Schedule III- Para A (7C) of Part A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30 January 2026 is enclosed as ‘Annexure-A’. Further, the Company has received confirmation from K S Ravindra, that there are no material reasons for his resignation other than those mentioned in his resignation letter, which is enclosed as ‘Annexure-B’. Further noted that this information shall also be made available on the website of the Company at www.surakshanet.com.
The above information is a part of company’s filings submitted to BSE.
Read More
May
19
2026
EQUITY Posted on May 19th 2026

Dhanvantri Jeevan Rekha submits board meeting intimation

Dhanvantri Jeevan Rekha has informed that pursuant to the Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), a Meeting of the Board of Directors of the Company will be held on Thursday, the 28th of May 2026 at 01:00 PM to consider and adopt The Audited Financial Statements for the quarter and year ended on 31st March, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
May
19
2026
EQUITY Posted on May 19th 2026

Carysil informs about analyst meet

Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Carysil has informed that the management of the Company will participating in the Investor Conference in one on-one meetings and group meetings as on May 28, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
May
19
2026
EQUITY Posted on May 19th 2026

POWERGRID Infrastructure Investment Trust informs about investor presentation

POWERGRID Infrastructure Investment Trust has informed that it enclosed Investor Presentation on the Financial Results of POWERGRID Infrastructure Investment Trust (PGInvIT) for the quarter and financial year ended March 31, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
May
19
2026
EQUITY Posted on May 19th 2026

Samyak International informs about board meeting

Samyak International has informed that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 to consider and approve Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and year ended on March 31, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the issue size of Suraksha Diagnostic Ltd. IPO?

The issue size of Suraksha Diagnostic Ltd. IPO is ₹564.17 - 592.37 crore.

The Suraksha Diagnostic Ltd. IPO opens for subscription on 2024-11-29 and closes on 2024-12-03.

The price range of Suraksha Diagnostic Ltd. IPO is ₹420.00 to ₹441.00.

The lot size of Suraksha Diagnostic Ltd. IPO is 34 shares.

The registrar of Suraksha Diagnostic Ltd. IPO is K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.).

Suraksha Diagnostic Ltd. IPO will be listed on BSE/NSE .

You will typically receive a confirmation message or notification from your broker or trading platform shortly after placing your IPO order. This confirms that your application has been submitted successfully. You can also check the order status in the IPO section of your trading account or app.

Apply early with valid UPI and PAN before 2024-12-03 to increase your chances.

The listing date of Suraksha Diagnostic Ltd. IPO is 2024-12-06.

An Initial Public Offering (IPO) is when a private company sells shares to the public for the first time, enabling investors to purchase these shares and gain partial ownership in the business. For instance, if a well-known tech firm wants to grow and requires additional funds, it might choose to go public through an IPO. During this process, investors can buy shares, and the company’s stock starts trading on the stock exchange on the day of the IPO listing.

Investors can apply for an IPO through their bank or brokerage account. Many trading platforms have a specific section for IPOs where users can submit their applications online.

The primary market is where shares are offered to the public for the first time via an IPO. After the IPO, shares are traded on the secondary market (stock exchange), where existing shareholders can sell to new buyers.

Investing in an IPO offers the opportunity to become an early investor in companies with high growth potential, at a price which may be lower than their post-listing market value. It provides a chance to participate in the company's growth journey from its early stages. However, IPO investments also come with inherent risks, such as market volatility and uncertainties about the company's future performance.

The price of an IPO is established through a systematic process known as "book building." In this method, investors bid within a given price range, and the final price is set based on demand and market conditions. Several factors play a crucial role in determining the IPO price, including:

Past Financial Performance: Evaluating the company's revenue, profits, and financial stability over time

Growth Potential: Assessing future prospects based on the company's business model and market opportunities

Industry Peers: Comparing valuation metrics with similar companies in the same sector

Larger Industry Picture: Analysing overall industry trends and economic conditions that could impact the company's performance

The lock-in period for IPO shares refers to a duration during which specific investors are restricted from selling their shares post-listing. This period varies based on the type of investor:

Promoters: The lock-in period for promoters ranges from 6 months to 18 months, ensuring their commitment to the company's long-term growth

Anchor Investors: Typically, anchor investors face a shorter lock-in period of 30 to 90 days, depending on regulatory norms and the specific IPO

IPOs can be volatile and may not perform as expected in the short term. Investors risk losing capital if the stock price drops after listing, especially if the company does not meet its growth projections.

Information on upcoming IPOs is often available through brokerage platforms, financial news sites, and regulatory bodies like SEBI, which publishes details on companies going public. You can also get these details under the upcoming IPO section on Bajaj Markets.

Eligibility for an IPO typically includes:

Retail Investors: Individuals who invest in smaller amounts, usually under the “retail investor” category, with certain limits

Qualified Institutional Buyers (QIBs): Entities like mutual funds, banks, and insurance companies, who invest large sums

Non-Institutional Investors (NIIs): High-net-worth individuals or entities investing above the retail threshold

Investors must have a Demat and trading account to apply, and in some cases, certain financial or residency qualifications may apply depending on local regulations.

SME (Small and Medium Enterprise) IPOs generally carry higher risk but may provide significant growth potential. Investors should research the company’s stability, financials, and sector risks, as SME stocks can be more volatile compared to large-cap companies.

View More

Invalid Mobile Number

Invalid Full Name

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore